D-0224-2021 Class III Terminated
FDA drug recall D-0224-2021 was initiated by KVK-Tech, Inc. on Dec 18, 2020 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications; out of specification results obtained for N-Oxide impurity during the 12-month long term stability testing for Batch# 15892A The recall status is terminated (terminated Mar 19, 2021). Affected quantity: 528 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 20, 2021
- Initiation Date
- Dec 18, 2020
- Termination Date
- Mar 19, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 528 bottles
Product description
Benzhydrocodone and Acetaminophen Tablets, CII, 6.12mg/ 325mg, 100 Tablets, Rx Only, Manufactured for: KVK-Tech, Inc., Newtown, PA 18940 USA, NDC 10702-344-01
Reason for recall
Failed Impurities/Degradation Specifications; out of specification results obtained for N-Oxide impurity during the 12-month long term stability testing for Batch# 15892A
Distribution pattern
Nationwide
Code information
Batch# 15892A, Exp, 2021-FEB
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0224-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026